JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collins, B. E.
Right arrow Articles by Schnaar, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collins, B. E.
Right arrow Articles by Schnaar, R. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 27, Issue of July 4, 1997 pp. 16889-16895
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Binding Specificities of the Sialoadhesin Family of I-type Lectins
SIALIC ACID LINKAGE AND SUBSTRUCTURE REQUIREMENTS FOR BINDING OF MYELIN-ASSOCIATED GLYCOPROTEIN, SCHWANN CELL MYELIN PROTEIN, AND SIALOADHESIN

(Received for publication, February 19, 1997, and in revised form, April 9, 1997)

Brian E. Collins Dagger , Makoto Kiso , Akira Hasegawa , Michael B. Tropak par , John C. Roder par , Paul R. Crocker ** and Ronald L. Schnaar Dagger

From the Dagger  Departments of Pharmacology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, the  Department of Applied Bioorganic Chemistry, Gifu University, Gifu 501-11, Japan, the par  Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto M5G 1X5, Canada, and the ** Imperial Cancer Research Fund Laboratories, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom

The carbohydrate binding specificities of three sialoadhesins, a subgroup of I-type lectins (immunoglobulin superfamily lectins), were compared by measuring lectin-transfected COS cell adhesion to natural and synthetic gangliosides. The neural sialoadhesins, myelin-associated glycoprotein (MAG) and Schwann cell myelin protein (SMP), had similar and stringent binding specificities. Each required an alpha 2,3-linked sialic acid on the terminal galactose of a neutral saccharide core, and they shared the following rank-order potency of binding: GQ1balpha >>  GD1a = GT1b >>  GM3 = GM4 >>  GM1, GD1b, GD3, GQ1b (nonbinders). In contrast, sialoadhesin had less exacting specificity, binding to gangliosides that bear either terminal alpha 2,3- or alpha 2,8-linked sialic acids with the following rank-order potency of binding: GQ1balpha  > GD1a = GD1b = GT1b = GM3 = GM4 > GD3 = GQ1b >>  GM1 (nonbinder). CD22 did not bind to any ganglioside tested. Binding of MAG, SMP, and sialoadhesin was abrogated by chemical modification of either the sialic acid carboxylic acid group or glycerol side chain on a target ganglioside. Synthetic ganglioside GM3 derivatives further distinguished lectin binding specificities. Deoxy and/or methoxy derivatives of the 4-, 7-, 8-, or 9-position of sialic acid attenuated or eliminated binding of MAG, as did replacement of the sialic acid acetamido group with a hydroxyl. In contrast, the 4- and 7-deoxysialic acid derivatives supported sialoadhesin binding at near control levels (the other derivatives did not support binding). These data are consistent with sialoadhesin binding to one face of the sialic acid moiety, whereas MAG (and SMP) may have more complex binding sites or may bind sialic acids only in the context of more restricted oligosaccharide conformations.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BrainHome page
P. H. H. Lopez, G. Zhang, M. A. Bianchet, R. L. Schnaar, and K. A. Sheikh
Structural requirements of anti-GD1a antibodies determine their target specificity
Brain, July 1, 2008; 131(7): 1926 - 1939.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. J. S. Yang, I. Lorenzini, K. Vajn, A. Mountney, L. P. Schramm, and R. L. Schnaar
Sialidase enhances spinal axon outgrowth in vivo
PNAS, July 18, 2006; 103(29): 11057 - 11062.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
A. Varki and T. Angata
Siglecs--the major subfamily of I-type lectins
Glycobiology, January 1, 2006; 16(1): 1R - 27R.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. A. Vyas, O. Blixt, J. C. Paulson, and R. L. Schnaar
Potent Glycan Inhibitors of Myelin-associated Glycoprotein Enhance Axon Outgrowth in Vitro
J. Biol. Chem., April 22, 2005; 280(16): 16305 - 16310.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
J. Sun, N. L. Shaper, S. Itonori, M. Heffer-Lauc, K. A. Sheikh, and R. L. Schnaar
Myelin-associated glycoprotein (Siglec-4) expression is progressively and selectively decreased in the brains of mice lacking complex gangliosides
Glycobiology, September 1, 2004; 14(9): 851 - 857.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
J. L. Sonnenburg, T. K. Altheide, and A. Varki
A uniquely human consequence of domain-specific functional adaptation in a sialic acid-binding receptor
Glycobiology, April 1, 2004; 14(4): 339 - 346.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Blixt, B. E. Collins, I. M. van den Nieuwenhof, P. R. Crocker, and J. C. Paulson
Sialoside Specificity of the Siglec Family Assessed Using Novel Multivalent Probes: IDENTIFICATION OF POTENT INHIBITORS OF MYELIN-ASSOCIATED GLYCOPROTEIN
J. Biol. Chem., August 15, 2003; 278(33): 31007 - 31019.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
B. P. Liu, A. Fournier, T. GrandPre, and S. M. Strittmatter
Myelin-Associated Glycoprotein as a Functional Ligand for the Nogo-66 Receptor
Science, August 16, 2002; 297(5584): 1190 - 1193.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Angata, S. C. Kerr, D. R. Greaves, N. M. Varki, P. R. Crocker, and A. Varki
Cloning and Characterization of Human Siglec-11. A RECENTLY EVOLVED SIGNALING MOLECULE THAT CAN INTERACT WITH SHP-1 AND SHP-2 AND IS EXPRESSED BY TISSUE MACROPHAGES, INCLUDING BRAIN MICROGLIA
J. Biol. Chem., June 28, 2002; 277(27): 24466 - 24474.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. A. Vyas, H. V. Patel, S. E. Fromholt, M. Heffer-Lauc, K. A. Vyas, J. Dang, M. Schachner, and R. L. Schnaar
From the Cover: Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration
PNAS, June 11, 2002; 99(12): 8412 - 8417.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. P. T. Lunn, T. O. Crawford, R. A. C. Hughes, J. W. Griffin, and K. A. Sheikh
Anti-myelin-associated glycoprotein antibodies alter neurofilament spacing
Brain, April 1, 2002; 125(4): 904 - 911.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
K. Nakamura, T. Yamaji, P. R. Crocker, A. Suzuki, and Y. Hashimoto
Lymph node macrophages, but not spleen macrophages, express high levels of unmasked sialoadhesin: implication for the adhesive properties of macrophages in vivo
Glycobiology, March 1, 2002; 12(3): 209 - 216.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Yamaji, T. Teranishi, M. S. Alphey, P. R. Crocker, and Y. Hashimoto
A Small Region of the Natural Killer Cell Receptor, Siglec-7, Is Responsible for Its Preferred Binding to alpha 2,8-Disialyl and Branched alpha 2,6-Sialyl Residues. A COMPARISON WITH Siglec-9
J. Biol. Chem., February 15, 2002; 277(8): 6324 - 6332.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Roseman
Reflections on Glycobiology
J. Biol. Chem., November 2, 2001; 276(45): 41527 - 41542.
[Full Text] [PDF]


Home page
GlycobiologyHome page
T. Angata and A. Varki
Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily
Glycobiology, April 1, 2000; 10(4): 431 - 438.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. C. M. Brinkman-Van der Linden and A. Varki
New Aspects of Siglec Binding Specificities, Including the Significance of Fucosylation and of the Sialyl-Tn Epitope
J. Biol. Chem., March 17, 2000; 275(12): 8625 - 8632.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. C. M. Brinkman-Van der Linden, E. R. Sjoberg, L. R. Juneja, P. R. Crocker, N. Varki, and A. Varki
Loss of N-Glycolylneuraminic Acid in Human Evolution. IMPLICATIONS FOR SIALIC ACID RECOGNITION BY SIGLECS
J. Biol. Chem., March 17, 2000; 275(12): 8633 - 8640.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
B. E. Collins, T. J. Fralich, S. Itonori, Y. Ichikawa, and R. L. Schnaar
Conversion of cellular sialic acid expression from N-acetyl- to N-glycolylneuraminic acid using a synthetic precursor, N-glycolylmannosamine pentaacetate: inhibition of myelin-associated glycoprotein binding to neural cells
Glycobiology, January 1, 2000; 10(1): 11 - 20.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. E. Collins, H. Ito, N. Sawada, H. Ishida, M. Kiso, and R. L. Schnaar
Enhanced Binding of the Neural Siglecs, Myelin-associated Glycoprotein and Schwann Cell Myelin Protein, to Chol-1 (alpha -Series) Gangliosides and Novel Sulfated Chol-1 Analogs
J. Biol. Chem., December 31, 1999; 274(53): 37637 - 37643.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Takematsu, S. Diaz, A. Stoddart, Y. Zhang, and A. Varki
Lysosomal and Cytosolic Sialic Acid 9-O-Acetylesterase Activities Can Be Encoded by One Gene via Differential Usage of a Signal Peptide-encoding Exon at the N Terminus
J. Biol. Chem., September 3, 1999; 274(36): 25623 - 25631.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Chammas, J. L. Sonnenburg, N. E. Watson, T. Tai, M. G. Farquhar, N. M. Varki, and A. Varki
De-N-acetyl-gangliosides in Humans: Unusual Subcellular Distribution of a Novel Tumor Antigen
Cancer Res., March 1, 1999; 59(6): 1337 - 1346.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H.-H. Chou, H. Takematsu, S. Diaz, J. Iber, E. Nickerson, K. L. Wright, E. A. Muchmore, D. L. Nelson, S. T. Warren, and A. Varki
A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence
PNAS, September 29, 1998; 95(20): 11751 - 11756.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. L. Cornish, S. Freeman, G. Forbes, J. Ni, M. Zhang, M. Cepeda, R. Gentz, M. Augustus, K. C. Carter, and P. R. Crocker
Characterization of Siglec-5, a Novel Glycoprotein Expressed on Myeloid Cells Related to CD33
Blood, September 15, 1998; 92(6): 2123 - 2132.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Razi and A. Varki
Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes
PNAS, June 23, 1998; 95(13): 7469 - 7474.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Angata and A. Varki
Cloning, Characterization, and Phylogenetic Analysis of Siglec-9, a New Member of the CD33-related Group of Siglecs. EVIDENCE FOR CO-EVOLUTION WITH SIALIC ACID SYNTHESIS PATHWAYS
J. Biol. Chem., July 14, 2000; 275(29): 22127 - 22135.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. W. van Rossenberg, L. A. J. M. Sliedregt, R. Autar, C. Piperi, A. P. Van der Merwe, T. J. C. van Berkel, J. Kuiper, and E. A. L. Biessen
A Structure-Function Study of Ligand Recognition by CD22beta
J. Biol. Chem., April 13, 2001; 276(16): 12967 - 12973.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.